🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
An open-label, single-arm, multicenter, prospective clinical study of Hanli...
Status
Recruiting
Location
Department of Oncology, The First Affiliated Hospital of Zhengzhou University
Start Date
2022-08-12
Trial ID
NCT05506410
Treatments Being Tested
This is a multicenter, open label, Phase 1 dose-escalation study of BBI608 ...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2015-05
Trial ID
NCT02352558
Treatments Being Tested
BACKGROUND: * Primary CNS lymphoma (PCNSL) is a rare subtype of diffuse la...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2014-08-14
Trial ID
NCT02203526
This research study is studying a drug called ibrutinib as a possible treat...
Status
Completed
Location
Massacusetts General Hospital
Start Date
2016-01
Trial ID
NCT02604511
Treatments Being Tested
Gemcitabine and nab-paclitaxel is a standard regimen (NCCN, Category 1) for...
Status
Completed
Location
University of California, San Francisco
Start Date
2015-10-12
Trial ID
NCT02562898
Treatments Being Tested
This randomized phase III trial studies ibrutinib to see how well it works ...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2016-10-12
Trial ID
NCT02443077
This is an open-label, Phase 2 study designed to assess the efficacy and sa...
Status
Completed
Location
Providence Saint Joseph Medical Center
Start Date
2013-12
Trial ID
NCT01980654
BLOOD-dose is a multicentre, adaptive, randomized, multidomain platform tri...
Status
Not Yet Recruiting
Location
Copenhagen University Hospital - Rigshospitalet
Start Date
2027-03
Trial ID
NCT07474961
The purpose of this study is to evaluate the efficacy and safety of PCI-327...
Status
Completed
Location
Multiple Locations
Start Date
2014-01-31
Trial ID
NCT01974440